Laserfiche WebLink
1)    ‍Administrative‍proceeding‍means‍a‍non-judicial‍process‍that‍is‍adjudicatory‍in‍ <br />nature‍in‍order‍to‍make‍a‍determination‍of‍fault‍or‍liability‍(e.g.,‍Securities‍and‍ <br />Exchange‍Commission‍Administrative‍proceedings,‍Civilian‍Board‍of‍Contract‍ <br />Appeals‍proceedings,‍and‍Armed‍Services‍Board‍of‍Contract‍Appeals‍proceedings).‍ <br />This‍includes‍proceedings‍at‍the‍Federal‍and‍State‍level‍but‍only‍in‍connection‍with‍ <br />performance‍of‍a‍Federal‍contract‍or‍grant.‍It‍does‍not‍include‍audits,‍site‍visits,‍ <br />corrective‍plans,‍or‍inspection‍of‍deliverables. <br />2)    ‍Conviction,‍for‍purposes‍of‍this‍award‍term‍and‍condition,‍means‍a‍judgment‍or‍ <br />conviction‍of‍a‍criminal‍offense‍by‍any‍court‍of‍competent‍jurisdiction,‍whether‍ <br />entered‍upon‍a‍verdict‍or‍a‍plea,‍and‍includes‍a‍conviction‍entered‍upon‍a‍plea‍of‍nolo‍ <br />contendere. <br />3)    ‍Total‍value‍of‍currently‍active‍grants,‍cooperative‍agreements,‍and‍procurement‍ <br />contracts‍includes— <br />a) ‍Only‍the‍Federal‍share‍of‍the‍funding‍under‍any‍Federal‍award‍with‍a‍ <br />recipient‍cost‍share‍or‍match;‍and <br />b) ‍The‍value‍of‍all‍expected‍funding‍increments‍under‍a‍Federal‍award‍and‍ <br />options,‍even‍if‍not‍yet‍exercised. <br />F. ‍Disclosure‍Requirements. <br />Consistent‍with‍45‍C.F.R.‍§‍75.113,‍applicants‍and‍recipients‍must‍disclose,‍in‍a‍timely‍manner,‍in‍ <br />writing‍to‍the‍HHS‍Awarding‍Agency,‍with‍a‍copy‍to‍the‍HHS‍Office‍of‍the‍Inspector‍General,‍all‍ <br />information‍related‍to‍violations‍of‍Federal‍criminal‍law‍involving‍fraud,‍bribery,‍or‍gratuity‍ <br />violations‍potentially‍affecting‍the‍Federal‍award.‍Subrecipients‍must‍disclose,‍in‍a‍timely‍manner,‍in‍ <br />writing‍to‍the‍prime‍recipient‍(pass‍through‍entity)‍and‍the‍HHS‍Office‍of‍the‍Inspector‍General‍all‍ <br />information‍related‍to‍violations‍of‍Federal‍criminal‍law‍involving‍fraud,‍bribery,‍or‍gratuity‍ <br />violations‍potentially‍affecting‍the‍Federal‍award.‍Disclosures‍must‍be‍sent‍in‍writing‍to‍the‍awarding <br />agency‍and‍to‍the‍HHS‍OIG‍at‍the‍following‍addresses: <br />HHS OASH Grants and Acquisitions Management <br />1101 Wootton Parkway, Plaza Level <br />Rockville, MD 20852 <br />AND <br />US Department of Health and Human Services Office of Inspector General <br />ATTN: OIG HOTLINE OPERATIONS—MANDATORY GRANT DISCLOSURES <br />PO Box 23489 <br />Washington, DC 20026 <br />URL:‍http://oig.hhs.gov/fraud/report-fraud/index.asp <br />(Include‍“Mandatory‍Grant‍Disclosures”‍in‍subject‍line) <br />Fax: 1-800-223-8164‍(Include‍“Mandatory‍Grant‍Disclosures”‍in‍subject‍line) <br />Failure‍to‍make‍required‍disclosures‍can‍result‍in‍any‍of‍the‍remedies‍described‍in‍45‍C.F.R.‍§ 75.371 <br />(“Remedies‍for‍noncompliance”),‍including‍suspension‍or‍debarment‍(See‍also‍2‍C.F.R.‍Parts‍180‍&‍ <br />376‍and‍31‍U.S.C.‍§‍3321). <br />14Page <br />Notice of Award <br />Award# <br />FAIN# <br />Federal Award Date:06/18/2021 <br />1 CPIMP211286-01-00 <br />CPIMP211286 <br />DEPARTMENT OF HEALTH AND HUMAN SERVICES <br />Office of the Secretary